After a lackluster 2022,the health care deal market will be defined this year by cash-rich strategics making calculated bets, a Bain & Co. report predicts.
Why it matters: Strategics are already primed to lead more venture capital raises, and their balance sheets suggest they'll be active buyers, too.
